Industry

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information. This … [Read more…]

QUEENSBURY, N.Y.–(BUSINESS WIRE)–Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to four individuals whose employment commenced in either November 2025 or … [Read more…]

New Apple iPad-powered technology replaces paper lists and helps security teams instantly recognize high-risk individuals at entry. AUSTIN, Texas–(BUSINESS WIRE)–#AthenaSecurity–Despite rising violence in U.S. healthcare settings, many hospitals still rely on manual, paper-based systems to identify potentially dangerous individuals, creating serious gaps in both physical security and reporting data. To close this gap, Athena Security, … [Read more…]

New industry-first study found total strain and sprain injuries were reduced when warehouse workers across five sites wore back exosuits. NASHVILLE, Tenn.–(BUSINESS WIRE)–#exosuit—HeroWear, an occupational exoskeleton provider, has announced breakthrough longitudinal safety data from five distribution centers over 8 to 23 months and a combined 311,000 work hours, signifying a 62% reduction in total strain … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the release of a letter to shareholders from its Founder, Chairman and Chief Executive Officer, … [Read more…]

LUSAKA, Zambia–(BUSINESS WIRE)–Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA), has announced a new partnership with leading Zambian pharmaceutical manufacturer Pharmanova Zambia Limited to expand access to life‑saving zinc treatments for children across Zambia. The collaboration was formally celebrated during a ceremony in Lusaka with the Zambian Ministry of Health, … [Read more…]

BEIJING–(BUSINESS WIRE)–Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the “Company”), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following … [Read more…]

Access to Acceleration: Agenus’ BOT+BAL Global Momentum Entering 2026 Webcast on Wednesday, January 28, 2026, at 4:00 p.m. ET LEXINGTON, Mass.–(BUSINESS WIRE)–$AGEN #Access—Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its first Stakeholder Webcast of 2026, Access to Acceleration: Agenus’ Global Momentum Entering 2026 on Wednesday, January 28, 2026, … [Read more…]

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Artemisinin Combination Therapy Market – Global Forecast 2026-2032” has been added to ResearchAndMarkets.com’s offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, … [Read more…]